Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
‘We’re good’ on weight loss: Biopharmas turn to muscle with new obesity drugs
8 months ago
R&D
Pharma
Cerebral to pay nearly $3.7M over controlled substance prescribing practices
8 months ago
Pharma
Health Tech
Why hospitals have been slow to adopt AI for medical care
8 months ago
AI
Health Tech
Q&A: Jade CEO talks about reverse merger and IgAN drugs
8 months ago
Deals
Evommune raises $115M for I&I pipeline and prepares for Phase 2 results
8 months ago
Financing
AbbVie adds to T cell engager momentum, with EvolveImmune pact starting at $65M
8 months ago
Deals
Pharma
Another Paragon offshoot inks reverse merger as Jade takes Aerovate’s place
8 months ago
Deals
Blue Earth Therapeutics snags $76M for both alpha and beta radiotherapies
8 months ago
Financing
A startup backed by Nobel winner David Baker takes an AI twist on antibodies
8 months ago
Financing
AI
Axonis snags $115M to test oral drugs for epilepsy and neuropathic pain
8 months ago
Financing
Corrected: Genmab lines up T cell engager pact with Revitope
8 months ago
Deals
Pharma
AbbVie makes $1.4B acquisition of Alzheimer's biotech
8 months ago
Deals
Pharma
Synaffix, industry's ADC partner of choice, spins out a startup pipeline
8 months ago
Financing
Former Seagen CEO David Epstein to lead new biotech with VEGF bifunctional antibody
8 months ago
R&D
FogPharma rebrands as Parabilis Medicines, as CEO Mathai Mammen highlights next drugs
8 months ago
R&D
Telix's new radiopharma spinout banks on one trial for success, CEO says
8 months ago
Manufacturing
Elucida Oncology, seeking foothold in ADCs, shutters due to 'lack of funding'
8 months ago
People
Septerna bags $288M upsized IPO for GPCR drugs
8 months ago
Financing
Sanofi backs fibrosis biotech Agomab as it raises $89M Series D
8 months ago
Financing
Pharma
Radiopharma startups stay hot as Alpha-9 bags $175M Series C
8 months ago
Financing
Life sciences investor Dimension seeks to raise $500M second fund
8 months ago
Financing
Houston startup March Biosciences raises $28M to get CAR-T into Phase 2
8 months ago
Financing
Cell/Gene Tx
Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder
8 months ago
Deals
Cell/Gene Tx
Be Bio raises $82M to fund work on B cell therapy in hemophilia B
8 months ago
Financing
R&D
First page
Previous page
8
9
10
11
12
13
14
Next page
Last page